These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 10468905)

  • 1. Evaluation of adrenal function in patients with hypothalamic and pituitary disorders: comparison of serum cortisol, urinary free cortisol and the human-corticotrophin releasing hormone test with the insulin tolerance test.
    Dullaart RP; Pasterkamp SH; Beentjes JA; Sluiter WJ
    Clin Endocrinol (Oxf); 1999 Apr; 50(4):465-71. PubMed ID: 10468905
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Evaluation of adrenal function in patients with growth hormone deficiency and hypothalamic-pituitary disorders: comparison between insulin-induced hypoglycemia, low-dose ACTH, standard ACTH and CRH stimulation tests.
    Maghnie M; Uga E; Temporini F; Di Iorgi N; Secco A; Tinelli C; Papalia A; Casini MR; Loche S
    Eur J Endocrinol; 2005 May; 152(5):735-41. PubMed ID: 15879359
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The assessment of the functional capacity of the hypothalamic-pituitary-adrenal axis by measurement of basal plasma and urinary cortisol in comparison with insulin-induced hypoglycaemia and metyrapone tests.
    de Lange WE; Sluiter WJ
    Neth J Med; 1993 Aug; 43(1-2):64-8. PubMed ID: 8232696
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Diagnosis of adrenal insufficiency: Evaluation of the corticotropin-releasing hormone test and Basal serum cortisol in comparison to the insulin tolerance test in patients with hypothalamic-pituitary-adrenal disease.
    Schmidt IL; Lahner H; Mann K; Petersenn S
    J Clin Endocrinol Metab; 2003 Sep; 88(9):4193-8. PubMed ID: 12970286
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparison of adrenal function tests in children--the glucagon stimulation test allows the simultaneous assessment of adrenal function and growth hormone response in children.
    Böttner A; Kratzsch J; Liebermann S; Keller A; Pfaffle RW; Kiess W; Keller E
    J Pediatr Endocrinol Metab; 2005 May; 18(5):433-42. PubMed ID: 15921172
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hexarelin as a test of pituitary reserve in patients with pituitary disease.
    Korbonits M; Kaltsas G; Perry LA; Grossman AB; Monson JP; Besser GM; Trainer PJ
    Clin Endocrinol (Oxf); 1999 Sep; 51(3):369-75. PubMed ID: 10469018
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hypothalamo-pituitary-adrenal axis dysfunction in chronic fatigue syndrome, and the effects of low-dose hydrocortisone therapy.
    Cleare AJ; Miell J; Heap E; Sookdeo S; Young L; Malhi GS; O'Keane V
    J Clin Endocrinol Metab; 2001 Aug; 86(8):3545-54. PubMed ID: 11502777
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A comparison of the naloxone test with ovine CRH and insulin hypoglycaemia in the evaluation of the hypothalamic-pituitary-adrenal axis in normal man.
    Inder WJ; Ellis MJ; Evans MJ; Donald RA
    Clin Endocrinol (Oxf); 1995 Oct; 43(4):425-31. PubMed ID: 7586616
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Diagnostic utility of the glucagon stimulation test in comparison to the insulin tolerance test in patients following pituitary surgery.
    Berg C; Meinel T; Lahner H; Yuece A; Mann K; Petersenn S
    Eur J Endocrinol; 2010 Mar; 162(3):477-82. PubMed ID: 19996199
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Evaluation of adrenal function using the human corticotrophin-releasing hormone test, low dose Synacthen test and 9am cortisol level in children and adolescents with central adrenal insufficiency.
    Maguire AM; Biesheuvel CJ; Ambler GR; Moore B; McLean M; Cowell CT
    Clin Endocrinol (Oxf); 2008 May; 68(5):683-91. PubMed ID: 18070143
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Investigation of the clinical significance of the growth hormone-releasing peptide-2 test for the diagnosis of secondary adrenal failure.
    Arimura H; Hashiguchi H; Yamamoto K; Shinnakasu A; Arimura A; Kikuchi A; Deguchi T; Habu M; Fujio S; Arita K; Nishio Y
    Endocr J; 2016 Jun; 63(6):533-44. PubMed ID: 27020037
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hyperprolactinaemia is associated with a higher prevalence of pituitary-adrenal dysfunction in non-functioning pituitary macroadenoma.
    Tjeerdsma G; Sluiter WJ; Hew JM; Molenaar WM; de Lange WE; Dullaart RP
    Eur J Endocrinol; 1996 Sep; 135(3):299-308. PubMed ID: 8890720
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Day 5 morning serum cortisol predicts hypothalamic-pituitary-adrenal function after transsphenoidal surgery for pituitary tumors.
    Jayasena CN; Gadhvi KA; Gohel B; Martin NM; Mendoza N; Meeran K; Dhillo WS
    Clin Chem; 2009 May; 55(5):972-7. PubMed ID: 19282356
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparison of one week 0900 h serum cortisol, low and standard dose synacthen tests with a 4 to 6 week insulin hypoglycaemia test after pituitary surgery in assessing HPA axis.
    Courtney CH; McAllister AS; McCance DR; Bell PM; Hadden DR; Leslie H; Sheridan B; Atkinson AB
    Clin Endocrinol (Oxf); 2000 Oct; 53(4):431-6. PubMed ID: 11012567
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Diagnosis of adrenal insufficiency using the GHRP-6 Test: comparison with the insulin tolerance test in patients with hypothalamic-pituitary-adrenal disease.
    Alaioubi B; Mann K; Petersenn S
    Horm Metab Res; 2010 Mar; 42(3):198-203. PubMed ID: 19946832
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The hypothalamic-pituitary-adrenal axis of patients with severe sepsis: altered response to corticotropin-releasing hormone.
    Schroeder S; Wichers M; Klingmüller D; Höfer M; Lehmann LE; von Spiegel T; Hering R; Putensen C; Hoeft A; Stüber F
    Crit Care Med; 2001 Feb; 29(2):310-6. PubMed ID: 11246311
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinical characteristics of patients with unexplainable hypothalamic disorder diagnosed by the corticotropin-releasing hormone challenge test: a retrospective study.
    Hataya Y; Okubo M; Hakata T; Fujimoto K; Iwakura T; Matsuoka N
    BMC Endocr Disord; 2022 Dec; 22(1):312. PubMed ID: 36494805
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Corticotrophin releasing factor: responses in normal subjects and patients with disorders of the hypothalamus and pituitary.
    Lytras N; Grossman A; Perry L; Tomlin S; Wass JA; Coy DH; Schally AV; Rees LH; Besser GM
    Clin Endocrinol (Oxf); 1984 Jan; 20(1):71-84. PubMed ID: 6319053
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Assessing the hypothalamo-pituitary-adrenocortical axis using physiological doses of adrenocorticotropic hormone.
    Talwar V; Lodha S; Dash RJ
    QJM; 1998 Apr; 91(4):285-90. PubMed ID: 9666951
    [TBL] [Abstract][Full Text] [Related]  

  • 20. An audit of the insulin tolerance test in adult subjects in an acute investigation unit over one year.
    Jones SL; Trainer PJ; Perry L; Wass JA; Bessser GM; Grossman A
    Clin Endocrinol (Oxf); 1994 Jul; 41(1):123-8. PubMed ID: 8050125
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.